1. Home
  2. FULC vs DDI Comparison

FULC vs DDI Comparison

Compare FULC & DDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FULC
  • DDI
  • Stock Information
  • Founded
  • FULC 2015
  • DDI 2008
  • Country
  • FULC United States
  • DDI South Korea
  • Employees
  • FULC N/A
  • DDI N/A
  • Industry
  • FULC Biotechnology: Pharmaceutical Preparations
  • DDI EDP Services
  • Sector
  • FULC Health Care
  • DDI Technology
  • Exchange
  • FULC Nasdaq
  • DDI Nasdaq
  • Market Cap
  • FULC 469.0M
  • DDI 444.0M
  • IPO Year
  • FULC 2019
  • DDI 2021
  • Fundamental
  • Price
  • FULC $8.73
  • DDI $8.98
  • Analyst Decision
  • FULC Buy
  • DDI Strong Buy
  • Analyst Count
  • FULC 6
  • DDI 5
  • Target Price
  • FULC $8.67
  • DDI $19.60
  • AVG Volume (30 Days)
  • FULC 524.6K
  • DDI 44.1K
  • Earning Date
  • FULC 11-12-2025
  • DDI 11-10-2025
  • Dividend Yield
  • FULC N/A
  • DDI N/A
  • EPS Growth
  • FULC N/A
  • DDI N/A
  • EPS
  • FULC N/A
  • DDI 2.15
  • Revenue
  • FULC N/A
  • DDI $333,256,000.00
  • Revenue This Year
  • FULC N/A
  • DDI $16.04
  • Revenue Next Year
  • FULC N/A
  • DDI $6.72
  • P/E Ratio
  • FULC N/A
  • DDI $4.13
  • Revenue Growth
  • FULC 2752.05
  • DDI 0.24
  • 52 Week Low
  • FULC $2.32
  • DDI $8.09
  • 52 Week High
  • FULC $9.88
  • DDI $18.21
  • Technical
  • Relative Strength Index (RSI)
  • FULC 54.66
  • DDI 38.31
  • Support Level
  • FULC $9.10
  • DDI $8.80
  • Resistance Level
  • FULC $9.88
  • DDI $9.15
  • Average True Range (ATR)
  • FULC 0.57
  • DDI 0.18
  • MACD
  • FULC -0.02
  • DDI -0.04
  • Stochastic Oscillator
  • FULC 56.24
  • DDI 24.60

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: